Prednisone Tapering: Evidence-Based Recommendations
The optimal prednisone taper involves gradually reducing the dose to 10 mg/day within 4-8 weeks, then reducing by 1 mg every 4 weeks until discontinuation. 1
General Principles
- Single daily dosing is preferred over divided doses to minimize adrenal suppression, except in special situations such as prominent night pain while on low doses (<5 mg daily) 1, 2
- Tapering is necessary for courses longer than 3 weeks to prevent adrenal insufficiency 1, 3
- Morning administration (before 9 am) is recommended to align with the body's natural cortisol peak and minimize HPA axis suppression 3
Specific Tapering Schedules Based on Initial Dose
High Initial Doses (>30 mg/day)
- Reduce to 10 mg/day within 4-8 weeks 1, 2
- Then taper more slowly at 1 mg every 4 weeks until discontinuation 1
- For immune-related adverse events: Start at 1-2 mg/kg/day, taper over 4-6 weeks once symptoms improve to grade 1 2
Medium Initial Doses (10-30 mg/day)
- Taper by 5 mg every week until reaching 10 mg/day 1
- Then slow the taper to 2.5 mg/week until reaching 5 mg/day 1
- For inflammatory conditions: Reduce to 10 mg/day within 4-8 weeks 2
Low Doses (<10 mg/day)
- Taper by 1 mg every 4 weeks 1, 4
- Alternative approach: Use 1.25 mg decrements with alternate-day schedules (e.g., 10/7.5 mg alternate days) 1
Disease-Specific Considerations
For Polymyalgia Rheumatica
- Initial dose: 12.5-25 mg prednisone equivalent daily 2
- Initial tapering: Reduce to 10 mg/day within 4-8 weeks 2, 1
- Maintenance tapering: Reduce by 1 mg every 4 weeks until discontinuation 2, 1
For Immune-Related Adverse Events
- For grade 2 events: Start with 0.5-1 mg/kg/day until symptoms improve to grade 1, then taper over 4-6 weeks 2
- For grade 3-4 events: Start with 1-2 mg/kg/day until symptoms improve to grade 1, then taper over 4-6 weeks 2
For Rheumatoid Arthritis
- Low doses (≤10 mg/day) are effective and should be tapered slowly using 1 mg decrements every 2-4 weeks 4
- Consider divided doses (e.g., 5 mg BID) if needed for symptom control 4
Managing Relapse During Tapering
- Return to the pre-relapse dose if symptoms recur 2, 1
- Once improved, gradually decrease within 4-8 weeks to the dose at which relapse occurred 2, 1
- Consider adding steroid-sparing agents if multiple relapses occur 1
Common Pitfalls to Avoid
- Tapering too quickly, which may lead to disease flare or adrenal insufficiency 1, 5
- Failing to monitor for steroid-related side effects during tapering 1
- Not providing calcium (800-1,000 mg/day) and vitamin D (400-800 units/day) supplementation to prevent osteoporosis 4
- Abrupt discontinuation of therapy, which can precipitate adrenal crisis 3
Special Considerations
- For short courses (<2 weeks), some evidence suggests that tapering may not be necessary, particularly in asthma exacerbations 6
- For chronic conditions requiring long-term therapy, alternate-day dosing may help minimize side effects 3, 1
- Recent evidence suggests that in some conditions (like myasthenia gravis), rapid tapering with appropriate immunosuppressive coverage may be as effective as slow tapering while reducing cumulative steroid exposure 7